T1D Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 16

Professionals
  • Investments
  • 41

  • Portfolio
  • 21

  • Exits
  • 9

Exits

T1D Fund General Information

Description

Founded in 2016, T1D Fund is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in biotech and pharma companies developing therapeutics, diagnostics, devices, and vaccines for people living with or at risk of developing type 1 diabetes sectors.

Contact Information

Website
t1dfund.org
Year Founded
2016
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 50 Milk Street
  • 16th Floor
  • Boston, MA 02109
  • United States
+1 (617) 000-0000

T1D Fund Investments (41)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Biolinq 17-Oct-2022 Later Stage VC 00000 Monitoring Equipment Clinical Trials - Phase 2
000000000 000000 14-Oct-2022 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
0000 000000000000 01-Jul-2022 00000 00000 Drug Discovery Generating Revenue
0000 000 25-May-2022 00000 00000 0000 Biotechnology Generating Revenue 0000 000000000 00.0
00000 10-May-2022 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000 0000 000000 29-Mar-2022 00000 00000 Drug Discovery Pre-Clinical Trials 00000 000000
00000000 11-Aug-2021 00000 00000 00000 Drug Discovery Generating Revenue
000000 00000000000 04-Aug-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials
Kriya 14-Jul-2021 Early Stage VC 00000 Drug Discovery Pre-Clinical Trials
Abata Therapeutics 23-Jun-2021 Early Stage VC 0000 Biotechnology Startup
You’re viewing 10 of 41 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

T1D Fund Exits (9)

Company Name Exit Date Exit Type Exit Size
Capillary Biomedical 21-Jul-2022 Merger/Acquisition 000.00
0000000000000 10-Sep-2021 000000000000000000 0000
00000000 000000000 14-Jul-2021 000000000000000000 000
0000000000 05-Feb-2021 000 00000
00000000 08-Jan-2021 000 00 00000000
000 0000000 30-Oct-2020 000 000.00
0000000 0000000000 17-Jul-2020 000 00000
Semma Therapeutics 10-Oct-2019 Merger/Acquisition 00000
Provention Bio 24-Jul-2018 IPO 000.00
To view T1D Fund’s complete exits history, request access »

T1D Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

T1D Fund Team (21)

Name Title Deals Funds Boards Office
Katie Ellias Managing Director & Member of Investment Committee 0 0 0 Boston, MA
Steven Peter MD Managing Director & Chairman of Investment Committee 0 Boston, MA
Bruce Buckingham MD Partner & Advisor Boston, MA
Carmella Evans-Molina Ph.D Partner & Advisor Boston, MA
Chantal Mathieu Ph.D Partner & Advisor Boston, MA
You’re viewing 5 of 21 team members. Get the full list »

T1D Fund Co-Investors (133)

Name With Exits Lead Partner Series Industry
Polaris Partners 3 0 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
Frazier Healthcare Partners 0 0 Series chart Industry bar
Genesys Capital 0 0 Series chart Industry bar
The Invus Group 0 0 0 Series chart Industry bar
You’re viewing 5 of 133 co-investors. Get the full list »